| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/29/2004 | US20040082032 Cctra gene as a tool to produce male-only progeny in the mediterranean fruitfly ceratitis capitata |
| 04/29/2004 | US20040082031 Polypeptides; genetic engineering; antibodies; cardiovascular disorders, antiinflammatory agents, anticholesterol agents, antitumor agents |
| 04/29/2004 | US20040082029 Autoimmune diseases; antiinflammatory agents; transgenic organism; binding to antibodies |
| 04/29/2004 | US20040082026 Viricides; heptatis virus; complexing of interferon with glycan |
| 04/29/2004 | US20040082017 Protein for drug screening; purification of lysosomes; fusion protein; nucleotide sequence coding polypeptide; quantitative analysis |
| 04/29/2004 | US20040082012 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 04/29/2004 | US20040082009 Compositions and methods for regulating receptor clustering |
| 04/29/2004 | US20040082003 Stem cell expansion enhancing factor and method of use |
| 04/29/2004 | US20040082002 Genetic engineering; screening antagonist; medical diagnosis using antibodies |
| 04/29/2004 | US20040081994 Measuring efficiency of exercise; measuring isotropic patterns; sensitivity to cardiovascular disorders |
| 04/29/2004 | US20040081992 Controlling gene expression; cell differentiation; drug screening; complexing, measuring binding |
| 04/29/2004 | US20040081988 Splice variant isoforms of human calcium channel CACNA1B |
| 04/29/2004 | US20040081986 Genetic engineering; libraries; lung cells; hybrids; process control; controlling activation; antiinflammatory agents; autoimmune diseases; infections; bone disorders; anticancer agents |
| 04/29/2004 | US20040081984 Ocular tear growth factor-like protein |
| 04/29/2004 | US20040081973 Cloning and characterization of a novel BK channel isoform highly expressed in glioma cells |
| 04/29/2004 | US20040081972 Detecting antibodies; screening, development therapies for infections, inflammation; polypeptides; monoclonal antibodies |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081970 Isolated nucleic acids; antibody for selective binding |
| 04/29/2004 | US20040081964 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 04/29/2004 | US20040081960 Novel process |
| 04/29/2004 | US20040081666 Cattle reproductive disease vaccines |
| 04/29/2004 | US20040081661 Papillomavirus truncated L1 protein and fusion protein constructs |
| 04/29/2004 | US20040081660 Polypeptide and protein derivatives and process for their preparation |
| 04/29/2004 | US20040081659 Conjugates useful in the treatment of prostate cancer |
| 04/29/2004 | US20040081658 Epitopes involved in the immune response to human papillomavirus; induction and/or enhancement of a T cell response directed towards an antigen, using peptides comprising specific epitopes for said antigen |
| 04/29/2004 | US20040081654 Use of plant oil-bodies in vaccine delivery systems |
| 04/29/2004 | US20040081653 Aberrantly over-expressed in at least some cancers, such as prostate and bladder cancers |
| 04/29/2004 | US20040081652 Administering an isolated molecule comprising an antibody variable region which specifically binds to a neuronal marker protein whereby neuronal cell death in the mammal is inhibited or prevented |
| 04/29/2004 | US20040081650 Inflammatory mediator antagonists |
| 04/29/2004 | US20040081640 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 04/29/2004 | US20040081637 Insertion target ligands into proteins; detection fluorescent signals; determination, calibration; gene therapy; antitumor agents |
| 04/29/2004 | US20040081636 Genetic engineering; polynucleotides |
| 04/29/2004 | DE10248301A1 Herstellung eines Lebend-Impfstoffes gegen Influenza-Viren Preparation of a live vaccine against influenza viruses |
| 04/29/2004 | CA2649821A1 Polynucleotide sequences encoding .delta.bcl-2 for preventing and treating autoimmune diseases |
| 04/29/2004 | CA2515650A1 New adenoviruses, nucleic acids coding therefor and their use |
| 04/29/2004 | CA2503145A1 Photoprotein with improved bioluminescence |
| 04/29/2004 | CA2502902A1 Method of producing recombinant proteins in the mammary gland of non-transgenic mammals |
| 04/29/2004 | CA2502863A1 Expressional enhancers from viruses |
| 04/29/2004 | CA2502539A1 Protein modification |
| 04/29/2004 | CA2502414A1 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 04/29/2004 | CA2502359A1 Susceptibility gene for myocardial infarction |
| 04/29/2004 | CA2502357A1 Susceptibility gene for myocardial infarction; methods of treatment |
| 04/29/2004 | CA2502324A1 Glucagon - like peptide - 2 variants |
| 04/29/2004 | CA2502316A1 Antagonists il-15 |
| 04/29/2004 | CA2502312A1 Transplantable cell with immune modulator |
| 04/29/2004 | CA2502243A1 A structured peptide scaffold for displaying turn libraries on phage |
| 04/29/2004 | CA2502152A1 E.coli host cells with modified phos/psts periplasmic phosphate-binding proteins, and method of manufacturing recombinant fabs |
| 04/29/2004 | CA2502029A1 Site specific incorporation of keto amino acids into proteins |
| 04/29/2004 | CA2501943A1 Orally administered peptides synergize statin activity |
| 04/29/2004 | CA2501874A1 Treating androgen decline in aging male (adam)-associated conditions with sarms |
| 04/29/2004 | CA2501867A1 Heterocyclic selective androgen receptor modulators and methods of use thereof |
| 04/29/2004 | CA2501836A1 Refolding of ionic channel proteins |
| 04/29/2004 | CA2501340A1 Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mammal obtained by implementing said method and said mammal's progeny |
| 04/29/2004 | CA2501333A1 Factor involved in metastasis and uses thereof |
| 04/29/2004 | CA2500653A1 Glycoprotein synthesis |
| 04/29/2004 | CA2500336A1 Improved immunotherapy |
| 04/29/2004 | CA2500295A1 Stabilized exendin-4 compounds |
| 04/29/2004 | CA2498194A1 Composition, method and use of bi-functional biomaterials |
| 04/29/2004 | CA2484760A1 Increasing host plant susceptibility to acrobacterium infection by overexpression of the arabidopsis vip1 gene |
| 04/29/2004 | CA2475053A1 Treatment of microbial infections and associated gastrointestinal disorders with thymosin .beta.4 |
| 04/28/2004 | EP1413884A1 Use of disease-associated gene |
| 04/28/2004 | EP1413626A1 Genes and proteins for the biosynthesis of the glycopeptide antibiotic A40926 |
| 04/28/2004 | EP1413587A2 Modified complement system regulator |
| 04/28/2004 | EP1413585A2 Novel, recombinantly produced spider silk analogs |
| 04/28/2004 | EP1413584A1 Photoprotein with improved bioluminescence |
| 04/28/2004 | EP1413583A2 Compounds that inhibit T cell proliferation and methods using the same |
| 04/28/2004 | EP1413316A1 Bifunctional conjugates or fusion proteins |
| 04/28/2004 | EP1413314A1 Medicinal compositions |
| 04/28/2004 | EP1413312A2 Therapeutic human albumin having a low aluminium binding activity |
| 04/28/2004 | EP1412757A2 Method for identification of proteins from intracellular bacteria |
| 04/28/2004 | EP1412750A2 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 04/28/2004 | EP1412748A2 Mage-a3 peptides presented by hla class ii molecules |
| 04/28/2004 | EP1412745A2 Edg : modulators of lymphocyte activation and migration |
| 04/28/2004 | EP1412538A2 Methods for the simultaneous detection of hcv antigens and hcv antibodies |
| 04/28/2004 | EP1412534A2 Method for determining the capacity of fusarium in producing trichothecene toxins |
| 04/28/2004 | EP1412527A2 Isp-1 and ctb-1 genes and uses thereof |
| 04/28/2004 | EP1412517A2 Methods, kits and compositions of combination oligomers |
| 04/28/2004 | EP1412513A2 Phosphate limited inducible promoter and a bacillus expression system |
| 04/28/2004 | EP1412508A2 Molecular vector for the genophenotypic characterisation of v3 sequences of hiv-1 gp120 |
| 04/28/2004 | EP1412506A2 Regulation of peroxisomal fatty acid transport in plants |
| 04/28/2004 | EP1412503A2 A fusion protein |
| 04/28/2004 | EP1412501A1 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof |
| 04/28/2004 | EP1412500A2 Nucleic acids coding for a isum2a polypeptide and use of said nucleic acids to obtain transformed plants producing seeds altered in germ development |
| 04/28/2004 | EP1412499A2 Cytokine polypeptides |
| 04/28/2004 | EP1412498A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 04/28/2004 | EP1412497A2 Engineered biosynthesis of polyenes |
| 04/28/2004 | EP1412496A2 Reversed mammalian protein-protein interaction trap |
| 04/28/2004 | EP1412492A2 Regulator of calcineurin |
| 04/28/2004 | EP1412485A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 04/28/2004 | EP1412482A2 Uses of opg ligand to modulate immune responses |
| 04/28/2004 | EP1412476A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/28/2004 | EP1412387A2 Transporters and ion channels |
| 04/28/2004 | EP1412386A2 USE OF PEPTIDE FRAGMENTS OF THE CALCIUM CHANNEL $g(A)-1 SUBUNIT, OPTIONALLY COMPRISING MUTATIONS, FOR SCREENING MOLECULES OF THERAPEUTIC INTEREST |
| 04/28/2004 | EP1412385A2 Modified insulin with reduced immunogenicity |
| 04/28/2004 | EP1412384A2 Stable formulation of modified glp-1 |
| 04/28/2004 | EP1412383A2 Peptides conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri) |
| 04/28/2004 | EP1412382A2 Interferon gamma polypeptide variants |
| 04/28/2004 | EP1412381A2 Meningococcus adhesins nada, app and orf40 |
| 04/28/2004 | EP1412380A1 New cationic peptides of the dermaseptin family isolated from the skin secretion of phyllomedusa hypochondrialis |
| 04/28/2004 | EP1412379A2 Antigenic polypeptides |